Anson Funds Management’s CervoMed CRVO Stock Holding History

Anson Funds Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,365	Closed	-$933K	–	37
2019 Q2	$933K	Buy	+4,365	New	+$1.18M	0.45%	16
2019 Q1	–	Sell	-442	Closed	-$66K	–	35
2018 Q4	$66K	Buy	+442	New	+$151K	0.04%	50

Other funds holding CRVO

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Anson Funds Management's CRVO Position: Q3 2019 in Review

Anson Funds Management sold out of CervoMed (CRVO) in Q3 2019, closing a stake of 4,365 shares — an estimated $933K sold.

Anson Funds Management first reported a position in CRVO in Q4 2018 and held it in 2 quarters. The position peaked at $933K in Q2 2019. 12 funds tracked by Wall St. Rank hold CRVO as of Q3 2019.

Anson Funds Management reported no remaining CervoMed position as of Q3 2019 after selling out during the quarter.
Anson Funds Management sold 4,365 CervoMed shares in Q3 2019, an estimated $933K.
Anson Funds Management first reported a position in CervoMed in Q4 2018 and held it in 2 quarters.
Anson Funds Management's CervoMed position peaked at $933K in Q2 2019.
12 funds tracked by Wall St. Rank held CervoMed as of Q3 2019.

Based on Anson Funds Management's 13F filing for Q3 2019, filed 14 Nov 2019.